UBS AM
CLBT icon

UBS AM’s Cellebrite CLBT Stock Holding History

UBS AM’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-207,826
Closed -$2.86M – 3742
2026
Q1 		$2.86M Sell
207,826
-282,392
-58% -$4.26M ﹤0.01% 1859
2025
Q4 		$8.84M Buy
+490,218
New +$8.8M ﹤0.01% 1174
2025
Q3 		– Sell
-288,736
Closed -$4.62M – 2349
2025
Q2 		$4.62M Buy
288,736
+115,723
+67% +$2.06M ﹤0.01% 1750
2025
Q1 		$3.36M Buy
173,013
+24,881
+17% +$524K ﹤0.01% 1762
2024
Q4 		$3.26M Buy
148,132
+36,341
+33% +$699K ﹤0.01% 1816
2024
Q3 		$1.88M Buy
111,791
+11,730
+12% +$174K ﹤0.01% 2066
2024
Q2 		$1.2M Buy
100,061
+63,661
+175% +$711K ﹤0.01% 2282
2024
Q1 		$403K Hold
36,400
– – ﹤0.01% 2342
2023
Q4 		$315K Hold
36,400
– – ﹤0.01% 2415
2023
Q3 		$278K Hold
36,400
– – ﹤0.01% 2452
2023
Q2 		$222K Hold
36,400
– – ﹤0.01% 2550
2023
Q1 		$222K Hold
36,400
– – ﹤0.01% 2550
2022
Q4 		$159K Hold
36,400
– – ﹤0.01% 2469
2022
Q3 		$143K Hold
36,400
– – ﹤0.01% 2649
2022
Q2 		$186K Hold
36,400
– – ﹤0.01% 2591
2022
Q1 		$233K Buy
36,400
+5,400
+17% +$35.8K ﹤0.01% 2648
2021
Q4 		$249K Buy
+31,000
New +$292K ﹤0.01% 2723

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

UBS AM's CLBT Position: Q2 2026 in Review

UBS AM sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 207,826 shares — an estimated $2.86M sold.

UBS AM first reported a position in CLBT in Q4 2021 and held it in 17 quarters. The position peaked at $8.84M in Q4 2025. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • UBS AM reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • UBS AM sold 207,826 Cellebrite shares in Q2 2026, an estimated $2.86M.
  • UBS AM first reported a position in Cellebrite in Q4 2021 and held it in 17 quarters.
  • UBS AM's Cellebrite position peaked at $8.84M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.